Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Antiviral Res. 2016 Dec 9;138:61–67. doi: 10.1016/j.antiviral.2016.12.006

Fig. 2. Kinase selectivity of XMD7 compounds.

Fig. 2

(A)–(C) Each compound (XMD7-1, -2 and -27, respectively) was subjected to Ambit KINOMEScan analysis. Each figure shows the 123 kinase proteins most potently inhibited by each compound. Full lists of kinase inhibition data for XMD7-1, -2 and -27 are shown in Tables S4–S6, respectively. Asterisks and crosses denote the ability of each compound to inhibit CLK proteins or CDK7, respectively.